Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Genetic characterization of three newly isolated CRF07_BC near full-length genomes in China.

Meng Z, Xing H, He X, Ma L, Xu W, Shao Y.

AIDS Res Hum Retroviruses. 2007 Aug;23(8):1049-54.


Founder effects in the assessment of HIV polymorphisms and HLA allele associations.

Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, Carlson J, Yusim K, McMahon B, Gaschen B, Mallal S, Mullins JI, Nickle DC, Herbeck J, Rousseau C, Learn GH, Miura T, Brander C, Walker B, Korber B.

Science. 2007 Mar 16;315(5818):1583-6.


Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China.

Zhao S, Zhai S, Zhuang Y, Wang S, Huang D, Kang W, Li X, Yu XG, Walker BD, Altfeld MA, Sun Y.

Curr HIV Res. 2007 Mar;5(2):251-9.


Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.

Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF.

PLoS One. 2007 Feb 21;2(2):e225.


Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.

Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, Cohen D, Allen TM, Rosenberg ES, Walker BD, Altfeld M.

J Virol. 2007 Apr;81(8):4199-214.


CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.

Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, McCutchan F, Njovu L, Geis S, Hoffmann O, Maboko L, Williamson C, Birx D, Meyerhans A, Cox J, Hoelscher M.

J Virol. 2007 Mar;81(5):2440-8.


CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.

Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn GH, Nickle D, Rousseau C, Coovadia H, Mullins JI, Heckerman D, Walker BD, Goulder P.

Nat Med. 2007 Jan;13(1):46-53.


AIDS epidemic at age 25 and control efforts in China.

Shao Y.

Retrovirology. 2006 Dec 1;3:87. Review.


Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection.

Day CL, Kiepiela P, Leslie AJ, van der Stok M, Nair K, Ismail N, Honeyborne I, Crawford H, Coovadia HM, Goulder PJ, Walker BD, Klenerman P.

J Virol. 2007 Jan;81(1):434-8.


Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.

Wang S, Zhuang Y, Zhai S, Zhao S, Kang W, Li X, Yu XG, Walker BD, Altfeld MA, Sun Y.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):780-7.


The challenges of host and viral diversity in HIV vaccine design.

Brander C, Frahm N, Walker BD.

Curr Opin Immunol. 2006 Aug;18(4):430-7. Review.


Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status.

Jiao Y, Xie J, Li T, Han Y, Qiu Z, Zuo L, Wang A.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):263-8.


Estimating the number of people at risk for and living with HIV in China in 2005: methods and results.

Lu F, Wang N, Wu Z, Sun X, Rehnstrom J, Poundstone K, Yu W, Pisani E.

Sex Transm Infect. 2006 Jun;82 Suppl 3:iii87-91.


Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.

Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P.

J Virol. 2006 Apr;80(7):3617-23.


Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.

Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, Hildebrand W, Altfeld M, Allen TM, Walker BD, Korber BT, Leitner T, Sanchez J, Brander C.

J Virol. 2006 Mar;80(6):3122-5.


Are all HIV type 1 strains created equal?

Campbell TB.

Clin Infect Dis. 2006 Mar 15;42(6):853-4. No abstract available.


HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA.

Blood. 2006 Jun 15;107(12):4781-9.


Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.

Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, Pae E, Wurcel AG, Roach T, St John MA, Altfeld M, Marincola FM, Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, Brander C.

Nat Immunol. 2006 Feb;7(2):173-8.


Is HIV-1 evolving to a less virulent (pathogenic) virus?

Quiñones-Mateu ME.

AIDS. 2005 Oct 14;19(15):1689-90. No abstract available.

Items per page

Supplemental Content

Support Center